Effect of ShengJiangXieXinTang on the intestinal mucosal immune barrier of rats receiving Irinotecan

DENG Hai-Yan,JIA Li-Qun,PAN Lin,YU Li-Li,LI Xue,GUO Yan-Ru
2007-01-01
Abstract:Objective:To observe modulation of gut functions and intestinal mucosal immune barrier by ShengJiangXieXinTang in rats receiving Irinotecan(CPT-11).Methods:Sprague Dawley male rats(n=18)were randomly assigned to three groups:(1)herb group (using ShengJiangXieXinTang by oral administration once a day from day 1 to day 9 and being injected with 150 mg/kg·d CPT-11 on day 4 and 5 into the tail vein); (2)diarrhea control group: using distilled water instead of ShengJiangXieXinTang,with the same treatment of CPT-11 as the herb group; (3)normal control group: using normal saline instead of CPT-11, distilled water instead of ShengJiangXieXinTang,and with the same treatment of as the CPT-11 herb group.The animals were scored in terms of delayed-onset of diarrhea. Rats were killed on day 10,collecting ileum,cecum and colon for pathological examination.The damages in intestinal mucosa were assessed under light microscope according to the criterion of chiu's score.CD4+,CD8+T-lymphocytes and SIgA were enumerated by immunohistochemical staining and calculated by imaging analyzer.Results:Compared with diarrhea control group,the incidence of diarrhea and the damage in intestinal mucosa of the herb group was milder(P<0.05, P<0.01); numbers of CD4+ and CD8+T lymphocytes and SIgA in rats’ intestinal tissue increased significantly(P<0.05).Conclusion:ShengJiangXieXinTang could improve composition of T-lymphocytes and SIgA synthesis in rats’ intestinal tissue, and it could prevent the delayed-onset of diarrhea caused by CPT-11.
What problem does this paper attempt to address?